Skip to content

Advancing the respiratory treatment market with low-emission propellants

Editor Rebekah Jordan spoke to Honeywell to explore its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients.

Advancing the respiratory treatment market with low-emission propellants
Published: | 2 min read

Editor Rebekah Jordan spoke to Honeywell  following its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients while reducing carbon emissions associated with the use of traditional inhalers.

Q. What makes Honeywell Solstice Air such an effective and environmentally friendly alternative to traditional propellants? 

Honeywell Solstice Air is an effective and environmentally friendly breakthrough alternative to traditional propellants due to its low global warming potential (GWP), non-ozone depleting properties and operational efficiency. The technology provides comparable or superior performance to conventional hydrofluorocarbons (HFCs) while being compliant with various global regulatory standards.  

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information